Do COPD treatment guidelines correctly address the treatment of smoking?
Unidad Especializada en Tabaquismo, Comunidad de Madrid, PII SEPAR de Tabaquismo, Madrid, España. Electronic address: carlos.jimenez@salud.madrid.org.
Carlos A
CA
Jiménez Ruiz
Servicio de Neumología, Hospital San Pedro de Alcántara, Cáceres, CIBERES, España.
Juan Antonio
JA
Riesco Miranda
D016642:Bupropion / Q000627:therapeutic use; D003863:Depression / Q000209:etiology; D006801:Humans; D018722:Nicotinic Agonists / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012907:Smoking / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods / Q000523:psychology; D000074606:Smoking Prevention; D012944:Social Support; D012955:Societies, Medical; D013030:Spain; D000073869:Tobacco Smoking / Q000009:adverse effects / Q000188:drug therapy / Q000517:prevention & control*; D014029:Tobacco Use Disorder / Q000188:drug therapy / Q000523:psychology / Q000534:rehabilitation
D018722:Nicotinic Agonists; D016642:Bupropion